/Companies

Epion Therapeutics</a> (Copy)

2 known investors

Find your way into Epion Therapeutics</a> (Copy)

Epion Therapeutics develops a minimally-invasive cross-linking treatment system called EpiSmart for keratoconus, a corneal disease, designed to preserve vision without disrupting the corneal epithelium. The company aims to bring early intervention treatment to patients globally.

Founders & leadership

MDMichael D. Webb
Michael D. WebbPresident & CEO, Board Member
EPEdward Parsons
Edward ParsonsChief Operating Officer
MWMichael W. Belin
Michael W. BelinChief Medical Officer

Investors · 2

Frequently asked questions

What does Epion Therapeutics</a> (Copy) do?
Epion Therapeutics develops a minimally-invasive cross-linking treatment system called EpiSmart for keratoconus, a corneal disease, designed to preserve vision without disrupting the corneal epithelium. The company aims to bring early intervention treatment to patients globally.
Who are Epion Therapeutics</a> (Copy)'s investors?
Epion Therapeutics</a> (Copy)'s investors include 7G BioVentures, New World Angels.